Skip to content
Sign in

CPHI · AMEX

China Pharma Holdings (CPHI) Stock Price & Fundamentals

$308.93−0.84%−$2.61End-of-day price as of Oct 9, 2026

China Pharma Holdings (CPHI) closed at $308.93 on Oct 9, 2026, down 0.84% from the previous close of $311.54.

Share price, past year

1Y +28.10%

52-week range $223.69 – $327.39. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$308.93
Sep 30, 2026$318.32
Aug 31, 2026$306.81
Jul 31, 2026$299.60
Jun 30, 2026$293.48
May 29, 2026$267.99
Apr 30, 2026$269.62
Mar 31, 2026$249.42
Feb 27, 2026$249.10
Jan 30, 2026$250.56
Dec 31, 2025$231.11
Nov 28, 2025$232.94
Oct 31, 2025$231.11

Key statistics

Market cap
$12.52B
P/E (TTM)
—
EPS (TTM)
−$0.41
Revenue (TTM)
$3.91M
Net income (TTM)
−$4.47M
Shares outstanding
40.5M
Dividend yield
—
52-week range
$223.69 – $327.39

China Pharma Holdings's market cap is $12.52B, based on a share price of $308.93 and 40.5M shares outstanding as of Jun 30, 2026.

Financials

China Pharma Holdings reported revenue of $4.14M for fiscal 2025, down 8.49% from fiscal 2024.

China Pharma Holdings reported a net loss of $3.19M in fiscal 2025.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
China Pharma Holdings annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$4.14M−8.5%−$3.19M−76.9%−$0.74$88.94K
FY2024ended Dec 31, 2024$4.53M−35.4%−$4.74M−104.6%−$2.71−$444.47K
FY2023ended Dec 31, 2023$7.01M−13.5%−$3.08M−43.9%−$0.91−$711.20K
FY2022ended Dec 31, 2022$8.10M−16.0%−$3.97M−49.0%−$3.78−$811.51K
FY2021ended Dec 31, 2021$9.64M−11.3%−$3.40M−35.3%−$0.74−$687.89K
FY2020ended Dec 31, 2020$10.87M−0.5%−$2.87M−26.4%—−$909.57K
FY2019ended Dec 31, 2019$10.92M−11.4%−$20.70M−189.5%—$472.31K
FY2018ended Dec 31, 2018$12.33M−6.7%−$10.75M−87.2%—$1.83M
FY2017ended Dec 31, 2017$13.21M−15.2%−$19.28M−145.9%—$704.74K
FY2016ended Dec 31, 2016$15.57M—−$9.18M−59.0%—$2.70M
China Pharma Holdings quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$948.34K−$1.46M−$0.04
Q1 FY2026ended Mar 31, 2026$983.54K−$1.14M−$0.04
Q4 FY2025ended Dec 31, 2025$1.23M−$1.22M—
Q3 FY2025ended Sep 30, 2025$756.22K−$651.48K−$0.17
Q2 FY2025ended Jun 30, 2025$1.03M−$528.37K−$0.16
Q1 FY2025ended Mar 31, 2025$1.14M−$785.57K−$0.24
Q4 FY2024ended Dec 31, 2024$1.13M−$1.22M—
Q3 FY2024ended Sep 30, 2024$1.10M−$1.12M−$0.65

Company profile

Name
China Pharma Holdings, Inc.
Ticker
CPHI
Exchange
AMEX
Industry (SEC SIC)
Pharmaceutical Preparations
Headquarters
2nd Floor, No. 17, Jinpan Road, Haikou, Hainan Province, F4 570216
Incorporated in
DE
Fiscal year ends
December
SEC CIK
0001106644

Recent SEC filings

Frequently asked questions

What is China Pharma Holdings's stock price?

China Pharma Holdings (CPHI) closed at $308.93 on Oct 9, 2026, down 0.84% from the previous close of $311.54.

What is China Pharma Holdings's market cap?

China Pharma Holdings's market cap is $12.52B, based on a share price of $308.93 and 40.5M shares outstanding as of Jun 30, 2026.

How much revenue does China Pharma Holdings make?

China Pharma Holdings reported revenue of $4.14M for fiscal 2025, down 8.49% from fiscal 2024.

Does China Pharma Holdings pay a dividend?

China Pharma Holdings's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from China Pharma Holdings, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures